Characterization of the Monkeypox Virus-Specific Immune Response in MPX-Cured Individuals

Scientists at the National Institute for Infectious Diseases in Rome, Italy have published a new study on the immune response of monkeypox virus (MPXV) in individuals who have recovered from the disease. The research team aimed to investigate the T-cell-specific response to MPXV in cured subjects using a whole blood platform.

Key Takeaways:

  • The study involved 16 MPX-cured subjects and 15 healthy donors (HD) with no recent vaccination history.
  • Whole blood was stimulated overnight with MPXV and VACV peptides to elicit CD4 and CD8 T-cell-specific responses.
  • MPX-cured subjects showed a significant IFN-g T-cell response to MPXV and VACV, indicating a mixed Th1- and Th2-response.
  • The study found that MPXV-specific responses were mainly induced by the CD4 peptides MPX-CD4-E and VACV-CD4.
  • The research suggests that the whole blood platform assay can be used to monitor the specific immunity induced by vaccination or infection.
  • The authors concluded that the study's findings can inform the development of effective vaccines and immunization strategies against MPXV.
  • The study was supported by financial supporters, including Eli Lilly, and was published in the journal Vaccines.

Statistics:

  • 16 MPX-cured subjects and 15 healthy donors participated in the study.
  • The study found that 13 out of 16 MPX-cured subjects showed a significant IFN-g T-cell response to MPXV and VACV.
  • The whole blood platform assay detected 9 cytokines, including IFN-g, IL-6, IP-10, IL-8, IL-2, G-CSF, MCP-1, MIP1-a, MIP-1b.
  • The study's results suggest that the CD4 peptides MPX-CD4-E and VACV-CD4 play a crucial role in inducing MPXV-specific responses.

Sources:

  • Petruccioli, E., Sbarra, S., Vita, S., Salmi, A., Cuzzi, G., De Marco, P., Matusali, G., Navarra, A., Pierelli, L., Grifoni, A., Sette, A., Maggi, F., Nicastri, E., & Goletti, D. (2024). Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response. Vaccines, 12(9), 1064. doi: 10.3390/vaccines12090964
  • NewsRx. New Monkeypox Research Reported from National Institute for Infectious Diseases (Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response). Vaccine Weekly. September 11, 2024; p 3778.